SymBio Pharmaceuticals Market Cap

SymBio Pharmaceuticals has a market cap or net worth of 8.19 billion as of March 5, 2026. Its market cap has decreased by -2.89% in one year.

Market Cap

8.19B

Enterprise Value

7.29B

Revenue

1.31B

Ranking

n/a

PE Ratio

n/a

Stock Price

128.00

Market Cap Chart

Since October 20, 2011, SymBio Pharmaceuticals's market cap has increased from 7.08B to 8.19B, an increase of 15.71%. That is a compound annual growth rate of 1.02%.

Market Cap History

Date	Market Cap	% Change
Mar 5, 2026	8.19B	63.03%
Dec 30, 2025	5.02B	-44.92%
Dec 30, 2024	9.12B	-12.48%
Dec 29, 2023	10.42B	-58.97%
Dec 30, 2022	25.40B	-42.20%
Dec 30, 2021	43.94B	203.74%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Fuso Pharmaceutical Industries,Ltd.	20.15B
Pharma Foods International	17.23B
Taiko Pharmaceutical	14.37B
Wakamoto Pharmaceutical	10.96B
Morishita Jintan	9.40B
Solasia Pharma K.K.	8.35B
WDB coco	6.40B
Nippon Chemiphar	6.24B

Market Cap Rankings